Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03818659 · ClinicalTrials.gov registry record · NA
Improving BP Control in Diverse Populations Using BP MAP
A NA study, sponsored by University of California, San Francisco.
- Completed
- Registry status
- NA
- Development phase
- 1,238,835
- Enrollment target
NCT03818659: Completed NA study, sponsored by University of California, San Francisco.
NCT03818659 is a NA study that has completed, run by University of California, San Francisco. The registered enrollment target is 1,238,835 participants, above the 1,382-participant average among 58,714 other NA trials with a reported enrollment target (89541% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03818659, a NA study, has completed, sponsored by University of California, San Francisco.
- COMPLETED
- Registry status
- NA
- Development phase
- 1,238,835 participants
- Enrollment target
Study Summary
BP-MAP is a cluster randomized controlled trial (RCT) designed to compare the effectiveness of BP lowering from a clinic-based quality improvement program with Full Support (dedicated practice facilitation) vs. a Self-Guided version of the program. The American Medical Association (AMA) developed the framework for the interventions.
Primary Outcome
The primary outcome will be clinic-level change in the proportion of patients with controlled BP from baseline to 6 months after the start of the intervention. BP control will be defined according to NQF 0018 as the percent of eligible patients (defined below) with SBP \<140 mmHg and DBP \< 90 mmHg, based on measurements obtained at the most recent ambulatory clinical encounter at baseline (using the lowest measures of SBP and DBP at that encounter) and similarly at the 6-month time point after
Interventions
- OTHER Self-Guided M.A.P. BP Improvement Program
- OTHER Full Support M.A.P. BP Improvement Program
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,238,835 participants |
| Start Date | 2019-07-01 |
| Est. Completion | 2021-06-30 |
| Phase | NA |
What the finished NCT03818659 record still lists
NCT03818659 is an interventional study that assigns participants to a tested intervention. Its 1,238,835 participants enrollment target places it among the larger protocols in the corpus, above the 1,382-participant average among 58,714 other NA trials with a reported enrollment target (89541% higher).
The record links to 0 conditions, and to 2 interventions - of which Self-Guided M.A.P. BP Improvement Program is the first listed.
NCT03818659 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03818659 about?
NCT03818659 is a clinical study titled "Improving BP Control in Diverse Populations Using BP MAP". BP-MAP is a cluster randomized controlled trial (RCT) designed to compare the effectiveness of BP lowering from a clinic-based quality improvement program with Full Support (dedicated practice facilitation) vs. a Self-Guided version of the program. The American Medical Association (AMA) developed th...
What is the current status of trial NCT03818659?
This trial is currently completed. It is a NA study. The enrollment target is 1,238,835 participants. The study started on 2019-07-01. Estimated completion is 2021-06-30.
What interventions are being tested in trial NCT03818659?
The interventions under investigation include: Self-Guided M.A.P. BP Improvement Program (OTHER), Full Support M.A.P. BP Improvement Program (OTHER).
Who is sponsoring clinical trial NCT03818659?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03818659's enrollment target sits among peer trials
1,238,835 1st of 2000 higher than 2,000 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT07022951 · 1,200,000 participants
The Million Anesthesia Cases Study (MACS) - a Cohort Study of Preoperative Fasting and Perioperative Outcomes
- NCT05066763 · 1,000,000 participants
Parkinson's Foundation Surveys
- NCT07075341 · 1,000,000 participants
Healthy Living BEYOND Weight Study
- NCT07224685 · 1,000,000 participants
A Study of Mayo Clinic CV Research Heart & Voice Study
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI